Inhalation technology that helps put you in front, faster
Biocare Manufacturing is a State-of-Art Manufacturing facility dedicated for the manufacturing of Metered Dose Inhalers. Our pharmaceuticals manufacturing unit have Malaysian GMP with PIC/S accreditation.
WHY TO CHOOSE
METER DOSE INHALERS
MDI has been the most widely used platform in the treatments for Asthma and COPD. It is estimated that there are 300 million asthma and 230 million COPD sufferers worldwide. MDIs are well suited to meet the needs of the price sensitive and largely generic developing world markets. Both MDIs and dry-powder inhalers (DPIs) combine to form a market valued at US$37 billion. Of the 920 million devices sold each year, MDIs represent about 60% of the volume and 40% of the sales value
WHY TO CHOOSE
BIOCARE’s MDI
- Expertise in Technologies
- Componentry – Advanced valve technology ensure dosing uniformity
Hardware Design – patient-friendly devices - Canister Design – Reduce drug degradation and deposition
- All components and hardware are sourced from UK to ensure 100% quality at
- par with any world class manufacturers
- State-of-Art fully dedicated for MDI plant with WHO-GMP, PIC/S Malaysia
- Approved plant
QUALITY CONTROL
We exercise a sound Quality Management System and adopting current Good Manufacturing Practices complying with all regulatory requirements. Our products are ready for registration with International standard ACTD / CTD Dossiers
OUR PRODUCTS
Single Drug Products
| Brand Name | Generic Name | Action | Strength | Metered Doses |
| Biomol | Salbutamol | Bronchodilators (Anti-cholinergic) |
100 mcg | 200 MD |
| Biozone | Beclomethasone | Anti inflammatory Agents Cortiscosteroids |
100 mcg | 200 MD |
Combination Products
| Brand Name | Generic Name | Action | Strength | Metered Doses |
| Salmetrol Fluticazone |
Salmetrol Fluticazone |
Anti-cholinergic + Bronchodilators |
25mg + 125 mcg | 120 MD |
| Salmetrol 25mg+ Fluticazone 250mcg |
Salmetrol 25mg+ Fluticazone 250mcg |
Bronchodilators + Corticosteroids |
25mg + 125 mcg | 120 MD |
Phase II Manufacturing
Biocare’s second phase manufacturing which is under construction now is expected to be commercialized by the end of 2022. The BCM-2 will manufacture Dry Powder Inhalers (DPIs), Nasal Sprays etc., to offer a complete range of Respiratory Medicines.
BCM-2 will be a fully integrated manufacturing facility with Malaysian GMP with PIC/S accreditation. The facility
| Brand Name | Generic Name |
| Dry Powder Inhaler | Budesonide |
| Fluticasone propionate | |
| Budesonide/formoterol | |
| Formeterol Fumarate | |
| Salmeterol + Fluticasone |
| Brand Name | Generic Name |
| Nasal Spray | Fluticasone |
| Oxymetazoline | |
| Saline Nasal Spray |